Combined impact of health risk factors on mortality of a petroleum industry population

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 8, 2009, Pages 916-921

  Tsai, Shan P ^a   Bhojani, Faiyaz A ^a   Wendt, Judy K ^a  

^a SHELL OIL COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; EMPLOYEE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PETROCHEMICAL INDUSTRY; PHYSICAL EXAMINATION; POPULATION RESEARCH; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 69549103430     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181ab59b0     Document Type: Article

References (36)

1. Pelletier KR. Clinical and cost outcomes of multifactorial cardiovascular risk management interventions in worksites: a comprehensive review and analysis. J Occup Environ Med. 1997;39:1154-1169.
2. Aldana SG, Pronk NP. Health promotion programs, modifiable health risks, and employee absenteeism. J Occup Environ Med. 2001;43:36-46.
3. Marshall AL. Challenges and opportunities for promoting physical activity in the workplace. J Sci Med Sport. 2004;7 (1 Suppl):60-66.
4. Tsai SP, Wendt JK, Ahmed FS, Donnelly RP, Strawmyer TR. Illness absence patterns among employees in a petrochemical facility: impact of selected health risk factors. J Occup Environ Med. 2005;47: 838-846.
5. Tsai SP, Donnelly RP, Wendt JK. Obesity and mortality in a prospective study of a middle-aged industrial population. J Occup Environ Med. 2006;48:22-27.
6. Riedel JE, Lynch W, Baase C, Hymel P, Peterson KW. The effect of disease prevention and health promotion on workplace productivity: a literature review. Am J Health Promot. 2001;15:167-191. (Pubitemid 32289174)
7. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The role of health related risk factors and disease on worker productivity. J Occup Environ Med. 1999;41:863-877. (Pubitemid 29501346)
8. Boles M, Pelletier B, Lynch W. The relationship between health risks and work productivity. J Occup Environ Med. 2004;46:737-745. (Pubitemid 38938250)
9. Cawley J, Rizzo JA, Haas K. Occupationspecific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med. 2007;49:1317-1324. (Pubitemid 351339828)
10. Schmier JK, Jones ML, Halpern MT. Cost of obesity in the workplace. Scand J Work Environ Health. 2006;32:5-11.
11. Bunn WB III, Stave GM, Downs KE, Alvir JM, Dirani R. Effect of smoking status on productivity loss. J Occup Environ Med. 2006;48:1099-1108. (Pubitemid 44569400)
12. Greenberg RS, Mandel JS, Pastides H, Britton NL, Rudenko L, Starr TB. A meta-analysis of cohort studies describing mortality and cancer incidence among chemical workers in the United States and Western Europe. Epidemiology. 2001;12:727-740. (Pubitemid 33134535)
13. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007; 298:2028-2037.
14. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993;153:598-615. (Pubitemid 23072389)
15. Joyner RE, Pack PH. The Shell Oil Company's computerized health surveillance system. J Occup Med. 1982;24:812-814. (Pubitemid 12035467)
16. Tsai SP, Gilstrap EL, Cowles SR, Snyder PJ, Ross CE. Long-term follow-up mortality study of petroleum refinery and chemical plant employees. Am J Ind Med. 1996;29:75-87.
17. SAS Institute, Inc. SAS Procedures Guide Release 8.12. Gary, NC: SAS Institute, Inc.; 1999.
18. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362:847-852. (Pubitemid 37130092)
19. U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service. Center for Disease Control. Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. DHHS Publication No. (CDC) 90-8416; 1990.
20. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham Heart Study. Circulation. 1983;67:968-977.
21. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999; 341:1097-1105. (Pubitemid 29466221)
22. McGee DL; The Diverse Population Collaboration Investigators. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005; 15:87-97.
23. Krieger DR, Landsberg L. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Am J Hypertens. 1988;1:84-90. (Pubitemid 18147675)
24. Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to high blood cholesterol levels in white American men. Arch Intern Med. 1993;153:1093-1103.
25. Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 1994;154:401-410.
26. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96:88-98.
27. Hertz RP, Unger AN, McDonald M, Lustik MB, Biddulph-Krentar J. The impact of obesity on work limitations and cardiovascular risk factors in the U.S. workforce. J Occup Environ Med. 2004; 46:1196-1203. (Pubitemid 39644023)
28. Flegal KM, Carroll MD, Kuczmarski RJ, Hohnson CL. Overweight and obesity in the United States-prevalence and trends 1960-1994. Int J Obes. 1998;22:39-47.
29. Chien LY, Liou YM, Chen JJ. Association between indices of obesity and fasting hyperglycemia in Taiwan. Int J Obes. 2004;28:690-696.
30. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009;41:77-81.
31. Woo M, Patti ME. Diabetes risk begins in utero. Cell Metab. 2008;8:5-7.
32. Daviglus ML, Stamler J, Pirzada A, et al. Favorable Cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA. 2004;292:1588-1592. (Pubitemid 39314965)
33. van Dam RM, Li T, Spiegelman D, Franco OH, Hu FB. Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ. 2008; 337:a1440.
34. Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008;5:e12. (Pubitemid 351198259)
35. Eberly LE, Prineas R, Cohen JD, et al. Multiple Risk Factor Intervention Trial Research Group. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care. 2006;29:123-130.
36. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med. 1998;158:2007-2014. (Pubitemid 28465625)